• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自鼻咽癌的纤溶酶原激活剂的鉴定。

Identification of a plasminogen activator derived from nasopharyngeal carcinoma.

作者信息

Kosugi T, Huang G W, Nakamura M, Koja S, Nong H T

机构信息

Department of Physiology, School of Medicine, University of the Ryukyus, Okinawa, Japan.

出版信息

Eur Arch Otorhinolaryngol. 1990;247(6):374-8. doi: 10.1007/BF00179011.

DOI:10.1007/BF00179011
PMID:2126177
Abstract

The activity of plasminogen activator (PA) in tissue extracts from nasopharyngeal carcinoma (NPC) was determined by means of the fibrin plate method. Development of PA activity was observed in 16 out of 25 cases investigated. Furthermore, using tissue extract of NPC with PA activity, characterization and identification of the activator were carried out by means of electrophoretic analysis, fibrin zymography and immunological analysis. The molecular weight of this PA was found to be 38,000 daltons. Additionally, a urokinase type of plasminogen activator was contained in the tissue extracts.

摘要

采用纤维蛋白平板法测定了鼻咽癌(NPC)组织提取物中纤溶酶原激活物(PA)的活性。在所研究的25例病例中,有16例观察到PA活性增强。此外,利用具有PA活性的NPC组织提取物,通过电泳分析、纤维蛋白酶谱分析和免疫分析对激活物进行了特性鉴定。发现该PA的分子量为38000道尔顿。此外,组织提取物中含有尿激酶型纤溶酶原激活物。

相似文献

1
Identification of a plasminogen activator derived from nasopharyngeal carcinoma.源自鼻咽癌的纤溶酶原激活剂的鉴定。
Eur Arch Otorhinolaryngol. 1990;247(6):374-8. doi: 10.1007/BF00179011.
2
Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase.
Andrologia. 1991 Jan-Feb;23(1):29-33. doi: 10.1111/j.1439-0272.1991.tb02488.x.
3
Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.采用纤维蛋白和非纤维蛋白检测法测定人肿瘤组织及相邻正常组织中的纤溶酶原激活物含量。
Cancer Res. 1986 Apr;46(4 Pt 1):1788-94.
4
Molecular characterization of plasminogen activators in human gingival crevicular fluid.人龈沟液中纤溶酶原激活剂的分子特征
Arch Oral Biol. 1995 Sep;40(9):839-45. doi: 10.1016/0003-9969(95)00049-u.
5
Distribution of plasminogen activator in different fractions of bovine milk.纤溶酶原激活剂在牛乳不同组分中的分布。
J Dairy Res. 1995 Feb;62(1):115-22. doi: 10.1017/s0022029900033720.
6
[The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].
Nihon Hinyokika Gakkai Zasshi. 1989 Nov;80(11):1558-65. doi: 10.5980/jpnjurol1989.80.1558.
7
Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity.
Int J Cancer. 1981 Feb 15;27(2):191-8. doi: 10.1002/ijc.2910270211.
8
Plasminogen activators in human malignant melanoma.人类恶性黑色素瘤中的纤溶酶原激活剂
J Natl Cancer Inst. 1984 Jun;72(6):1213-22.
9
Characterization of plasminogen activator from two human renal carcinoma cell lines.两种人肾癌细胞系纤溶酶原激活物的特性分析
J Cell Physiol. 1986 Mar;126(3):435-43. doi: 10.1002/jcp.1041260315.
10
Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.
Invasion Metastasis. 1985;5(6):344-55.

引用本文的文献

1
The concentration of u-PA and PAI-1 antigen in tissue extracts of nasopharyngeal carcinoma.鼻咽癌组织提取物中尿激酶型纤溶酶原激活物(u-PA)和纤溶酶原激活物抑制剂-1(PAI-1)抗原的浓度。
Eur Arch Otorhinolaryngol. 1997;254(6):277-80. doi: 10.1007/BF02905987.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Fibrin in human tumors.人类肿瘤中的纤维蛋白。
Cancer Res. 1960 Jun;20:592-3.
3
TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATE.用硫酸鱼精蛋白治疗恶性疾病
Lancet. 1964 Feb 22;1(7330):408-9. doi: 10.1016/s0140-6736(64)92787-4.
4
Effect of human plasmin on the toxic effects and growth of blood borne metastatis of the Brown-Pearce carcinoma and the V2 carcinoma of rabbit.
Cancer. 1956 Nov-Dec;9(6):1147-52. doi: 10.1002/1097-0142(195611/12)9:6<1147::aid-cncr2820090613>3.0.co;2-u.
5
Fibrinolytic activity of human tumors as measured by the fibrin-plate method.用人纤维蛋白平板法测定的人类肿瘤的纤溶活性。
Cancer. 1955 Nov-Dec;8(6):1146-54. doi: 10.1002/1097-0142(1955)8:6<1146::aid-cncr2820080610>3.0.co;2-w.
6
The fibrin plate method for estimating fibrinolytic activity.用于评估纤维蛋白溶解活性的纤维蛋白平板法。
Arch Biochem Biophys. 1952 Oct;40(2):346-51. doi: 10.1016/0003-9861(52)90121-5.
7
Plasminogen activator activity and composition in human breast cancer.人类乳腺癌中的纤溶酶原激活物活性与成分
Cancer Res. 1982 Jan;42(1):219-26.
8
Urokinase-like plasminogen activator as a marker of endometrial neoplasia.尿激酶型纤溶酶原激活剂作为子宫内膜肿瘤的标志物。
Cancer. 1981 Sep 15;48(6):1484-6. doi: 10.1002/1097-0142(19810915)48:6<1484::aid-cncr2820480634>3.0.co;2-l.
9
Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck.十种源自头颈部鳞状癌的人类癌细胞系。
Br J Cancer. 1981 Jun;43(6):772-85. doi: 10.1038/bjc.1981.115.
10
Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.人肺肿瘤和正常肺组织中纤溶酶原激活剂的含量及特性
Cancer Res. 1980 Mar;40(3):841-8.